Farmak JSC, the leading manufacturer of neurological and endocrinologic drugs in Ukraine, has developed and launched on the market a new antiepileptic drug, Meditan® (active ingredient: gabapentin) that comes in capsules.
Meditan® is intended for treatment of partial epileptic seizures with or without secondary generalization in adults and children (in combination with other antiepileptic drugs for children over 6 or as a monotherapy for children over 12). The new drug may also be used for treatment of associated nerve pain in adults with diabetic neuropathy and postherpetic neuralgia.
Vlast Deneg [The Power of Money] magazine has published the rating of TOP 25 successful marketing campaigns held in the Ukrainian market in 2020 – the first half of 2021. The rating includes marketing projects implemented by both domestic companies and Ukrainian representative offices of foreign companies. The leaders include: Farmak, Carlsberg Ukraine, Avon...
Each city or town has its own traditions. We follow the old and develop the new ones ourselves. It has become a good tradition for Farmak to congratulate Shostka on its Town Day in a sporty way. The anniversary race “Farmak: Run for Your Health” has been held by the Company for the fifth time. […]
The 5th anniversary race organized by Farmak on the occasion of Shostka Town Day will be held with the support of the local authorities in an offline format under the motto “Run a race and take care of your health!” The race will take place on September 3 in Shostka as part of the celebration of […]